How big is the Atrial Fibrillation Market ?
Global Atrial Fibrillation Market reached USD 19.3 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 42.8 billion by 2031.
Who are the Key Players of Atrial Fibrillation Market ?
The major global players include AtriCure, Biosense Webster, Boehringer Ingelheim GmbH, Boston Scientific Corporation, Bristol-Myers Squibb Corporation, Cardio Focus, Endoscopic Technologies, Sanofi Aventis, Abbott and Johnson and Johnson.